Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
On WRAL at 11: Rain popping up on the DualDoppler 5000 radar. When it moves out and the newest track for Hurricane Rafael
Program
Thursday on WRAL at 6: Violence against healthcare workers is surging! WRAL Investigates why the people caring for us fear for their lives at work
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Rallybio Corporaton
(NQ:
RLYB
)
1.000
-0.020 (-1.96%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Rallybio Corporaton
< Previous
1
2
3
4
5
6
Next >
RCI Hospitality, AbCellera Biologics And Some Other Big Stocks Moving Higher On Thursday
December 15, 2022
U.S. stocks traded lower, with the Dow Jones dropping over 600 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Rallybio Announces Publication of Data Highlighting the Ability of HPA-1a-Specific Antibodies to Prevent Alloimmunization in an Authentic Mouse Model of FNAIT
December 15, 2022
From
Rallybio Corporation
Via
Business Wire
Dow Jumps 600 Points; US Inflation Rate Slows In November
December 13, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining over 600 points on Tuesday
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
December 12, 2022
Monday saw 196 companies set new 52-week lows.
Via
Benzinga
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 13, 2022
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 09, 2022
Via
Benzinga
Rallybio's Thrombocytopenia Candidate Shows Rapid, Complete Elimination Of Transfused Platelets
September 28, 2022
Via
Benzinga
AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases
December 01, 2022
From
Rallybio Corporation
Via
Business Wire
Rallybio to Present at the JMP Securities Hematology and Oncology Summit
November 29, 2022
From
Rallybio Corporation
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
November 11, 2022
Gainers
Via
Benzinga
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
November 14, 2022
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday.
Via
Benzinga
Why Compass Shares Are Trading Higher By Over 56%? Here Are 63 Stocks Moving In Friday's Mid-Day Session
November 11, 2022
Gainers Snail, Inc. (NASDAQ: SNAL) shares jumped 74.9% to $3.9350 after the company announced a $5 million share repurchase program.
Via
Benzinga
Rallybio to Present at Upcoming Investor Conferences in November
November 11, 2022
From
Rallybio Corporation
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
November 11, 2022
On Friday, 63 stocks hit new 52-week lows.
Via
Benzinga
Rallybio Announces Pricing of $50 Million Public Offering
November 10, 2022
From
Rallybio
Via
Business Wire
Rallybio Announces Proposed Public Offering
November 10, 2022
From
Rallybio Corporation
Via
Business Wire
Rallybio Reports Third Quarter 2022 Financial Results
November 07, 2022
From
Rallybio Corporation
Via
Business Wire
Rallybio Announces Positive Phase 1 Single Ascending Dose Results for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5
November 07, 2022
From
Rallybio Corporation
Via
Business Wire
Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday
October 05, 2022
Losers
Via
Benzinga
Peering Into Rallybio's Recent Short Interest
October 04, 2022
Rallybio's (NASDAQ:RLYB) short percent of float has fallen 4.94% since its last report. The company recently reported that it has 638 thousand shares sold short, which is 2.5% of all regular shares...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 04, 2022
Gainers
Via
Benzinga
Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session
October 04, 2022
Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday.
Via
Benzinga
FaZe Holdings, AXT And Some Other Big Stocks Moving Lower On Tuesday
October 04, 2022
U.S. stocks traded higher, with the Dow Jones gaining more than 700 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Rallybio Announces Positive Preliminary Results for RLYB212, an anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia
September 28, 2022
From
Rallybio Corporation
Via
Business Wire
Rallybio to Present at the 2022 Wells Fargo Healthcare Conference
August 31, 2022
From
Rallybio Corporation
Via
Business Wire
Rallybio Reports Second Quarter 2022 Financial Results
August 08, 2022
From
Rallybio Corporation
Via
Business Wire
Rallybio Appoints Wendy K. Chung, M.D., Ph.D., to Its Board of Directors
August 02, 2022
From
Rallybio Corporation
Via
Business Wire
69 Biggest Movers From Friday
June 06, 2022
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 03, 2022
Via
Benzinga
40 Stocks Moving In Friday's Mid-Day Session
June 03, 2022
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.